Viridian Therapeutics Inc. (0K1R)
Market Closed
17 Jul, 15:30
LSE 
$
18. 05
+0.15
+0.8267%
$
- Market Cap
- P/E Ratio
- Div Yield
1,320 Volume
-4.96 Eps
$ 17.9
Previous Close Want to track 0K1R and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Viridian Therapeutics Inc. (0K1R) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.5B
Trailing P/E (ttm) -5.18
Forward P/E -
PEG ratio -1.18
Price/Sales (ttm) 22.88
Price/Book (mrq) 2.9
Enterprise Value/Revenue 21.12
Enterprise Value/EBITDA -4.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.23K
Average volume (90 days) 6.9K
Price summary
52-Week low 13.25
52-Week high 34.31
Beta -
50-Day moving average 17.7
200-Day moving average 22.75
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 21 Sep 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.08%
Operating margin -5.44%
Operational effectiveness
Return on assets -0.46%
Return on equity -0.61%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.69
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.46
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 15.15%
Book value per share (mrq) 6.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
